MLTX MoonLake Immunotherapeutics
Nasdaq · SEC CIK 1821586 · EDGAR
- Bought, last 12 months
- $98.8K 1 purchases by 1 insiders
- Sold, last 12 months
- $129.89M 17 sales by 5 insiders
- Filings on record
- 79 since 2022-04-07, latest 2026-07-29 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BVF PARTNERS L P/IL | Dir, 10% | — | $62.96M |
| Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | — | $46.87M |
| Santos da Silva Jorge | CEO, Dir | — | $8.73M |
| Reich Kristian | CSO | — | $8.14M |
| Bodenstedt Matthias | CFO | $98.8K | $3.20M |
Transactions 69
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TI | 2026-07-29 16:10 | 2026-07-27 | MLTX | Reich Kristian | CSO | S - Sale | $20.00 | -1,100 | 2.71M | -0.0% | -$22.0K |
| MTI | 2026-07-23 16:05 | 2026-07-21+ | MLTX | Reich Kristian | CSO | S - Sale | $20.02 | -52.4K | 2.71M | -2% | -$1.05M |
| TI | 2026-07-21 18:13 | 2026-07-20 | MLTX | Reich Kristian | CSO | S - Sale | $20.09 | -43.7K | 2.76M | -2% | -$877.9K |
| TI | 2026-07-20 06:07 | 2026-07-15 | MLTX | Reich Kristian | CSO | S - Sale | $20.01 | -16.1K | 2.81M | -0.6% | -$322.3K |
| MT | 2026-07-13 16:10 | 2026-07-09+ | MLTX | Santos da Silva Jorge | CEO, Dir | S - Sale | $20.02 | -102.2K | 2.77M | -4% | -$2.05M |
| T | 2026-07-02 16:10 | 2026-07-01 | MLTX | Santos da Silva Jorge | CEO, Dir | S - Sale | $20.03 | -47.8K | 2.88M | -2% | -$956.9K |
| T | 2026-06-23 16:01 | 2026-06-22 | MLTX | Bodenstedt Matthias | CFO | S - Sale | $22.04 | -39.1K | 1.12M | -3% | -$862.2K |
| MT | 2026-06-18 18:45 | 2026-06-17+ | MLTX | Bodenstedt Matthias | CFO | S - Sale | $19.67 | -17.9K | 1.15M | -2% | -$351.6K |
| MTI | 2026-06-17 18:15 | 2026-06-15+ | MLTX | Reich Kristian | CSO | S - Sale | $19.01 | -150.0K | 2.82M | -5% | -$2.85M |
| T | 2026-05-13 16:10 | 2026-05-11 | MLTX | Bodenstedt Matthias | CFO | S - Sale | $20.02 | -13.7K | 1.17M | -1% | -$273.3K |
| T | 2026-04-16 16:10 | 2026-04-14 | MLTX | Bodenstedt Matthias | CFO | S - Sale | $19.56 | -2,426 | 1.19M | -0.2% | -$47.5K |
| M | 2026-04-14 17:55 | 2026-04-10+ | MLTX | Santos da Silva Jorge | CEO, Dir | S - Sale | $18.35 | -150.0K | 2.92M | -5% | -$2.75M |
| MT | 2026-04-10 18:06 | 2026-04-09+ | MLTX | Bodenstedt Matthias | CFO | S - Sale | $18.95 | -87.8K | 1.19M | -7% | -$1.66M |
| M | 2026-04-02 16:48 | 2026-03-31 | MLTX | BVF PARTNERS L P/IL | Dir, 10% | S - Sale | $16.79 | -3.75M | 1.04M | -78% | -$62.96M |
| 2026-01-09 | 2026-01-07 | MLTX | Bodenstedt Matthias | CFO | A - Grant | $0.00 | +354.3K | 1.28M | +38% | $0 | |
| D | 2025-12-22 | 2025-12-19 | MLTX | Bodenstedt Matthias | CFO | C - Cnv Deriv | — | +294.5K | 922.0K | +47% | — |
| D | 2025-12-22 | 2025-12-19 | MLTX | Bodenstedt Matthias | CFO | D - Sale to Iss | — | -294.5K | 0 | -100% | — |
| D | 2025-12-22 | 2025-12-19 | MLTX | Santos da Silva Jorge | CEO, Dir | D - Sale to Iss | — | -196.3K | 0 | -100% | — |
| D | 2025-12-22 | 2025-12-19 | MLTX | Santos da Silva Jorge | CEO, Dir | C - Cnv Deriv | — | +196.3K | 3.07M | +7% | — |
| D | 2025-12-22 | 2025-12-19 | MLTX | Reich Kristian | CSO | D - Sale to Iss | — | -35.4K | 0 | -100% | — |
| D | 2025-12-22 | 2025-12-19 | MLTX | Reich Kristian | CSO | C - Cnv Deriv | — | +35.4K | 35.4K | New | — |
| M | 2025-12-10 | 2025-12-08+ | MLTX | Reich Kristian | CSO | S - Sale | $14.85 | -202.9K | 0 | -100% | -$3.01M |
| M | 2025-12-10 | 2025-12-08+ | MLTX | Santos da Silva Jorge | CEO, Dir | S - Sale | $14.87 | -200.0K | 2.95M | -6% | -$2.97M |
| 2025-10-09 | 2025-10-08 | MLTX | Bodenstedt Matthias | CFO | P - Purchase | $9.09 | +10.9K | 627.5K | +2% | +$98.8K | |
| MI | 2025-10-01 | 2025-09-29+ | MLTX | Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | S - Sale | $7.21 | -6.50M | 2.00M | -76% | -$46.87M |
| D | 2025-09-04 | 2025-09-02 | MLTX | Reich Kristian | CSO | D - Sale to Iss | — | -49.0K | 35.4K | -58% | — |
| D | 2025-09-04 | 2025-09-02 | MLTX | Reich Kristian | CSO | C - Cnv Deriv | — | +49.0K | 202.9K | +32% | — |
| D | 2025-07-07 | 2025-07-03 | MLTX | Moukheibir Catherine | Dir | S - Sale+OE | $48.79 | -23.5K | 0 | -100% | -$1.15M |
| D | 2025-07-07 | 2025-07-03 | MLTX | Moukheibir Catherine | Dir | M - OptEx | $0.00 | +23.5K | 23.5K | New | $0 |
| 2025-03-03 | 2025-02-27 | MLTX | Bodenstedt Matthias | CFO | A - Grant | $0.00 | +95.8K | 616.7K | +18% | $0 | |
| 2025-03-03 | 2025-02-27 | MLTX | Santos da Silva Jorge | CEO, Dir | A - Grant | $0.00 | +95.8K | 3.08M | +3% | $0 | |
| D | 2025-01-22 | 2025-01-20 | MLTX | Reich Kristian | CSO | D - Sale to Iss | — | -111.9K | 84.4K | -57% | — |
| D | 2025-01-22 | 2025-01-20 | MLTX | Reich Kristian | CSO | C - Cnv Deriv | — | +111.9K | 153.9K | +267% | — |
| M | 2024-10-08 | 2024-10-04 | MLTX | BVF I GP LLC | Dir, 10% | S - Sale | $50.00 | -2.00M | 10.24M | -16% | -$100.00M |
| 2024-10-08 | 2024-10-04 | MLTX | Sturge Simon | Dir | S - Sale | $53.72 | -171.0K | 172.0K | -50% | -$9.19M | |
| M | 2024-02-29 | 2024-02-27+ | MLTX | Reich Kristian | CSO | S - Sale | $55.00 | -57.5K | 70.1K | -45% | -$3.16M |
| MI | 2024-02-29 | 2024-02-27+ | MLTX | Reich Kristian | CSO | S - Sale | $55.00 | -61.4K | 2.93M | -2% | -$3.38M |
| M | 2024-02-29 | 2024-02-27+ | MLTX | Santos da Silva Jorge | CEO, Dir | S - Sale | $55.03 | -123.6K | 3.04M | -4% | -$6.80M |
| 2024-02-23 | 2024-02-21 | MLTX | Santos da Silva Jorge | CEO, Dir | S - Sale | $55.27 | -1,125 | 3.11M | -0.0% | -$62.2K | |
| MI | 2024-02-22 | 2024-02-20+ | MLTX | Reich Kristian | CSO | S - Sale | $57.35 | -10.5K | 2.99M | -0.4% | -$602.7K |
| M | 2024-02-22 | 2024-02-20+ | MLTX | Reich Kristian | CSO | S - Sale | $57.32 | -10.6K | 99.5K | -10% | -$605.8K |
| M | 2024-02-20 | 2024-02-15+ | MLTX | Santos da Silva Jorge | CEO, Dir | S - Sale | $59.26 | -60.0K | 3.13M | -2% | -$3.56M |
| MI | 2024-02-16 | 2024-02-14+ | MLTX | Reich Kristian | CSO | S - Sale | $60.91 | -30.0K | 3.02M | -1.0% | -$1.83M |
| M | 2024-02-16 | 2024-02-14+ | MLTX | Reich Kristian | CSO | S - Sale | $60.91 | -30.0K | 120.1K | -20% | -$1.83M |
| M | 2023-12-21 | 2023-12-19+ | MLTX | Bodenstedt Matthias | CFO | S - Sale | $59.17 | -100.0K | 520.9K | -16% | -$5.92M |
| I | 2023-10-10 | 2023-10-05 | MLTX | Cormorant Private Healthcare Fund II, LP | 10% | P - Purchase | $59.90 | +58.8K | 8.49M | +0.7% | +$3.52M |
| MI | 2023-10-04 | 2023-10-02+ | MLTX | Cormorant Private Healthcare Fund IV LP | 10% | P - Purchase | $57.30 | +293.2K | 8.37M | +4% | +$16.80M |
| DM | 2023-10-03 | 2023-10-01 | MLTX | Santos da Silva Jorge | CEO, Dir | C - Cnv Deriv | — | +3.17M | 3.03M | New | — |
| DM | 2023-10-03 | 2023-10-01 | MLTX | Santos da Silva Jorge | CEO, Dir | D - Sale to Iss | — | -3.17M | 217.4K | -94% | — |
| D | 2023-10-03 | 2023-10-01 | MLTX | Sturge Simon | Dir | D - Sale to Iss | — | -343.0K | 0 | -100% | — |
| D | 2023-10-03 | 2023-10-01 | MLTX | Sturge Simon | Dir | C - Cnv Deriv | — | +343.0K | 343.0K | New | — |
| D | 2023-10-03 | 2023-10-01 | MLTX | Bodenstedt Matthias | CFO | D - Sale to Iss | — | -63.0K | 294.5K | -18% | — |
| D | 2023-10-03 | 2023-10-01 | MLTX | Bodenstedt Matthias | CFO | C - Cnv Deriv | — | +63.0K | 620.9K | +11% | — |
| DI | 2023-10-03 | 2023-10-01 | MLTX | Reich Kristian | CSO | D - Sale to Iss | — | -2.53M | 0 | -100% | — |
| D | 2023-10-03 | 2023-10-01 | MLTX | Reich Kristian | CSO | D - Sale to Iss | — | -42.0K | 196.3K | -18% | — |
| D | 2023-10-03 | 2023-10-01 | MLTX | Reich Kristian | CSO | C - Cnv Deriv | — | +42.0K | 140.1K | +43% | — |
| DI | 2023-10-03 | 2023-10-01 | MLTX | Reich Kristian | CSO | C - Cnv Deriv | — | +2.53M | 3.03M | +505% | — |
| I | 2023-07-05 | 2023-06-30 | MLTX | Chen Bihua | 10% | P - Purchase | $50.00 | +800.0K | 4.93M | +19% | +$40.00M |
| MI | 2023-06-28 | 2023-06-26 | MLTX | Chen Bihua | 10% | P - Purchase | $45.63 | +450.0K | 4.10M | +12% | +$20.54M |
| D | 2023-04-07 | 2023-04-05 | MLTX | Reich Kristian | CSO | D - Sale to Iss | — | -98.1K | 238.3K | -29% | — |
| D | 2023-04-07 | 2023-04-05 | MLTX | Reich Kristian | CSO | C - Cnv Deriv | — | +98.1K | 98.1K | New | — |
| DI | 2023-04-07 | 2023-04-05 | MLTX | Reich Kristian | CSO | C - Cnv Deriv | — | +500.0K | 500.0K | New | — |
| DI | 2023-04-07 | 2023-04-05 | MLTX | Reich Kristian | CSO | D - Sale to Iss | — | -500.0K | 2.53M | -17% | — |
| DM | 2023-04-07 | 2023-04-05 | MLTX | Bodenstedt Matthias | CFO | D - Sale to Iss | — | -557.9K | 357.4K | -61% | — |
| DM | 2023-04-07 | 2023-04-05 | MLTX | Bodenstedt Matthias | CFO | C - Cnv Deriv | — | +557.9K | 557.9K | New | — |
| MI | 2023-03-22 | 2023-03-20+ | MLTX | Chen Bihua | 10% | P - Purchase | $20.28 | +827.1K | 3.30M | +33% | +$16.77M |
| D | 2022-04-07 | 2022-04-05 | MLTX | Helix Holdings LLC | Former 10% Holder | C - Cnv Deriv | $0.00 | +2.79M | 3.21M | +648% | $0 |
| DI | 2022-04-07 | 2022-04-05 | MLTX | Chen Bihua | 10% | P - Purchase | $10.00 | +2.85M | 2.85M | New | +$28.50M |
| DI | 2022-04-07 | 2022-04-05 | MLTX | Chen Bihua | 10% | C - Cnv Deriv | $0.00 | +2.79M | 3.21M | +648% | $0 |
Purchase Sale Sale after option exercise All abbreviations